XML 33 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statement of Cash Flow (Parenthetical) (Unaudited) (USD $)
Mar. 31, 2010
Feb. 28, 2010
Calando Pharmaceuticals, Inc [Member]
Nov. 30, 2009
Calando Pharmaceuticals, Inc [Member]
Mar. 31, 2006
Calando Pharmaceuticals, Inc [Member]
Sep. 30, 2010
Calando Pharmaceuticals, Inc [Member]
Series A Preferred Stock
Apr. 20, 2007
Carbon Nanotechnologies, Inc
Series E Preferred Stock
Sep. 28, 2009
Unidym, Inc [Member]
Apr. 23, 2008
Unidym, Inc [Member]
Sep. 22, 2010
Unidym, Inc [Member]
Series A Preferred Stock
Jun. 11, 2009
Unidym, Inc [Member]
Series A Preferred Stock
Nov. 30, 2010
Unidym, Inc [Member]
Series C Preferred Stock
Jun. 25, 2009
Unidym, Inc [Member]
Series C Preferred Stock
Nov. 30, 2009
Unidym, Inc [Member]
Series C-1 Preferred Stock
Mar. 23, 2005
Insert Therapeutics, Inc
Apr. 29, 2008
MASA Energy LLC
Aug. 08, 2008
Nanoconduction, Inc
Noncash Investing and Financing Items [Abstract]                                
Purchase of common shares   200,000 2,850,000 964,000 1,562.5     200,000           7,375,000    
Common stock, shares issued   8,000 114,000 20,838   143,122 64,227 7,054 9,149 132,462 15,317 194,444 27,777 50,226 10,504 11,411
Common stock value     $ 706,800 $ 1,077,333   $ 5,400,000 $ 398,209   $ 46,662 $ 688,802 $ 47,485 $ 972,222 $ 186,111 $ 2,000,000 $ 310,000 $ 250,000
Value of common stock purchased       1,928,000                     560,000  
Stock puchased by cash       $ 850,667       $ 200,000             $ 250,000  
Warrants issued   2,400 24,000   390,625                      
Warrants purchased   60,000 600,000                          
Common stock exercise value   $ 5     $ 5                      
Warrants exercised 24,788                              
Stock issued against warrants 12,870